Literature DB >> 3134996

Treatment for mild hyperparathyroidism.

.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3134996      PMCID: PMC2545848          DOI: 10.1136/bmj.296.6633.1398-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  9 in total

1.  Treatment of primary hyperparathyroidism.

Authors:  D C Purnell; D A Scholz; L H Smith; G W Sizemore; M B Black; R S Goldsmith; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

2.  Primary hyperparathyroidism: a prospective clinical study.

Authors:  D C Purnell; L H Smith; D A Scholz; L R Elveback; C D Arnaud
Journal:  Am J Med       Date:  1971-05       Impact factor: 4.965

3.  Hyperparathyroidism: experiences with treated and untreated patients.

Authors:  P G Rohl; M Wilkinson; P Clifton-Bligh; S Posen
Journal:  Med J Aust       Date:  1981-05-16       Impact factor: 7.738

4.  Asymptomatic primary hyperparathyroidism. 10-year prospective study.

Authors:  D A Scholz; D C Purnell
Journal:  Mayo Clin Proc       Date:  1981-08       Impact factor: 7.616

5.  Long term follow up of untreated primary hyperparathyroidism.

Authors:  C R Paterson; J Burns; E Mowat
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

6.  Primary hyperparathyroidism: the case for medical management.

Authors:  W Van'T Hoff; F W Ballardie; E J Bicknell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

7.  Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979.

Authors:  M Palmér; H O Adami; R Bergström; G Akerström; S Ljunghall
Journal:  Surgery       Date:  1987-07       Impact factor: 3.982

8.  The conservative management of primary hyperparathyroidism.

Authors:  M J Sampson; W van't Hoff; E J Bicknell
Journal:  Q J Med       Date:  1987-12

9.  Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up.

Authors:  M Palmer; H O Adami; R Bergström; S Jakobsson; G Akerström; S Ljunghall
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.